Although Stighall et al disclosed that high ID2 protein expression was associated with a favorable prognosis in primary breast cancer [14], a majority of investigations showed an adverse effect of ID2 overexpression on clinical outcome in diverse cancer types. Here, ID2 is linked to breast carcinoma.